A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2011
10/19/2011	EP2376112A2 MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES
10/19/2011	EP2376111A1 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/19/2011	EP2376093A2 Methods of treating or preventing biofilm associated infections with free available chlorine water
10/19/2011	EP2376092A2 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens
10/19/2011	EP2376078A2 Deuterated compounds as hepatitis c virus (hcv) inhibitors
10/19/2011	EP2221377B1 Oligonucleotide compositions with enhanced efficiency
10/19/2011	EP1782816B1 Water-based medicinal composition containing azithromycin and method of preparing the same
10/19/2011	EP1640371B1 Flavanone compound and uses thereof
10/19/2011	EP1451338B1 Recombinant antibodies for the detection and neutralization of anthrax toxin
10/19/2011	EP1372735B1 Conjugate of hydroxyalkyl starch and an active agent
10/19/2011	EP1165132B1 Dry formulation for transcutaneous immunization
10/19/2011	EP1041982B1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/19/2011	CN1977907B Eriobotuya japonica extract, and composition containing same and use
10/19/2011	CN1913919B HIV vaccines based on env of multiple clades of hiv
10/19/2011	CN102224252A Novel compound signamycin, method for production thereof, and use thereof
10/19/2011	CN102224242A Novel gene cluster
10/19/2011	CN102224171A Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection
10/19/2011	CN102221618A Method for establishing hog cholera lapinized virus labeled vaccine strain and preparing vaccine
10/19/2011	CN102220362A Technique for constructing bait alga capable of effectively expressing antibacterial peptide and application method
10/19/2011	CN102220357A Multivalent vaccines comprising recombinant viral vectors
10/19/2011	CN102220298A Ferulic acid esterase FaeI as well as coding gene and application thereof
10/19/2011	CN102220293A Dog flu recombinant virus as well as preparation method and application thereof
10/19/2011	CN102220291A Duck flavivirus and inactivated vaccine thereof
10/19/2011	CN102220287A Avian infectious bronchitis cold adaptation attenuated vaccine strain and application thereof
10/19/2011	CN102220283A Multifunctional immune killing transgenic cell as well as preparation method and use thereof
10/19/2011	CN102220272A Method for high density culture of haemophilus parasuis for preparing vaccines
10/19/2011	CN102220271A Marine Streptomyces strain and use thereof
10/19/2011	CN102220263A Mycoplasma bovis attenuated strain and application thereof
10/19/2011	CN102220256A Yeast expression system for expressing HAS-Vmip-II fusion protein and construction method thereof
10/19/2011	CN102220255A Recombinant antimicrobial peptide (AMP) as well as genetic engineering preparation method and application thereof
10/19/2011	CN102219847A Defensin mNP-1 and applications thereof in preparing anti-influenza virus drugs
10/19/2011	CN102219845A Half-smooth tongue sole hepcidin antimicrobial peptide
10/19/2011	CN102219837A Recombinant full-length A-type botulinum toxin mutant vaccine
10/19/2011	CN102219831A Antibiotic peptide as well as preparation method and application thereof
10/19/2011	CN102219815A Six tiacumicins compounds, preparation method and use of six tiacumicins compounds in preparing antibacterial drugs
10/19/2011	CN102219772A Cortex pseudolaricis acid complex with bioactivity and preparation method thereof
10/19/2011	CN102219768A Perylenequinone compounds and their extraction and separation method and use
10/19/2011	CN102219753A Triazole compounds as well as preparation method and application thereof
10/19/2011	CN102219751A Pentadienone-containing 4-substituted quinazoline derivative, preparation method and use thereof
10/19/2011	CN102219750A N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
10/19/2011	CN102219725A Benzohetercyclic compound as well as preparation method and applications thereof
10/19/2011	CN102219717A N-phenyl aryl formamide derivative, preparation method thereof and use thereof
10/19/2011	CN102219705A Crystallization process of columnar crystal of L-serine and application of columnar crystal
10/19/2011	CN102219687A Elephantopus scaber extract as well as preparation method and applications thereof in preparing antiviral drugs
10/19/2011	CN102219686A Caffeoyl derivative and use of coffeeoyl derivative in preparing drugs against respiratory syncytial viruses
10/19/2011	CN102218149A Medical ultrasonic couplant capable of disinfection and sterilization and preparation technology thereof
10/19/2011	CN102218144A Method for regulating content of micro-ribonucleic acids in organism and use thereof
10/19/2011	CN102218142A Method for enhancing bacteriostatic effect of deep fungal-infection resistant antifungal medicament
10/19/2011	CN102218139A Medicament for treating and/or preventing viral infection
10/19/2011	CN102218138A 免疫原性组合物 The immunogenic composition
10/19/2011	CN102218136A Anti-reovirus oral gene engineering vaccine and its preparation method
10/19/2011	CN102218092A Dispersion tablets of traditional Chinese medicine composition
10/19/2011	CN102218087A Method for preparing total flavone extracts of pagoda flower
10/19/2011	CN102218079A Biological colloid dispersant used for wound-protection and its preparation method
10/19/2011	CN102218078A Rifaximin suspension containing montmorillonite and preparation method thereof
10/19/2011	CN102218060A Amoxicillin and probenecid compound suspension injection for livestock and preparation method thereof
10/19/2011	CN102218059A Aztreonam-compound-containing composition
10/19/2011	CN102218052A Application of kaempferol as synergist of anti-fungal medicaments
10/19/2011	CN102218048A Application of magnolol in preparation of external preparations and daily chemical products for treating dermatosis caused by malassezia
10/19/2011	CN102218047A Medicament for treating drug-resistant bacteria infection, and application of active ingredient thereof in pharmacy
10/19/2011	CN102218039A Formula, preparation method and use of potassium sodium dehydroandroan drographolide succinate liposome combined medicament
10/19/2011	CN102218034A Formula, preparation method and use of azithromycin liposome combined medicament
10/19/2011	CN102218033A Formula, preparation method and use of alprostadil liposome combined medicament
10/19/2011	CN102218031A Formula, preparation method and use of lactose-azithromycin liposome combined medicine
10/19/2011	CN102218029A Formula, preparation method and use of pefloxacin mesylate liposome combined medicament
10/19/2011	CN101978994B Method for judging active ingredients of rhubarb
10/19/2011	CN101940651B Traditional Chinese medicine superfine powder for preventing and treating chicken colibacillosis and preparation method thereof
10/19/2011	CN101926774B Azithromycin powder composite and preparation method thereof
10/19/2011	CN101904949B Plant extract liquor and preparation method thereof
10/19/2011	CN101849916B Cefpiramide sodium powder injection and preparation method thereof
10/19/2011	CN101838250B New application of thio-taxane derivatives
10/19/2011	CN101785766B Lidocaine and chlorhexidine aerosol
10/19/2011	CN101703469B Preparation method and products of danofloxacin mesylate liposome
10/19/2011	CN101700257B Pomegranate peel polyphenol antibiosis and antiphlogosis effervescent tablet as well as preparation method and application thereof
10/19/2011	CN101697966B Application of furanodiene in preparation of medicaments for treating diseases caused by viruses
10/19/2011	CN101612344B Compound Chinese herbal medicine preparation for preventing and treating oosperm block saprolegniasis of spot furcate-tail leiocassis longirostris
10/19/2011	CN101570515B Curcumin substituted uracil derivative, preparation method and use thereof
10/19/2011	CN101550189B Anthropogenic antivirulin glycosidoprotein neutralizing genetic engineering antibody RD9 and preparation and application thereof
10/19/2011	CN101439151B Medicament for treating beriberi
10/19/2011	CN101304995B Thiazole derivatives and use thereof
10/18/2011	US8039488 Methods and compositions for inhibition of angiogenesis
10/18/2011	US8039458 HIV integrase inhibitors
10/18/2011	US8039454 Macrolide compounds with antibiotic and antineoplastic properties
10/18/2011	US8039452 Antifungal medicinal compositions
10/18/2011	US8039444 Antisense permeation enhancers
10/18/2011	CA2503730C Cytarabine monophosphate prodrugs
10/18/2011	CA2494049C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/18/2011	CA2478813C Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/18/2011	CA2475312C N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
10/18/2011	CA2462345C Dimeric compounds and their use as anti-viral agents
10/18/2011	CA2440644C Inhibitors of integrin .alpha.v.beta.6
10/18/2011	CA2434927C Pharmaceutical compositions with antibiotic activity
10/18/2011	CA2391843C Hcv vaccine compositions
10/18/2011	CA2360275C Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/18/2011	CA2337328C Biocompatible polymers, preparation method and compositions containing same
10/18/2011	CA2311492C Vaccines with an ltb adjuvant
10/13/2011	WO2011127179A1 Glycomimetic compounds and methods to inhibit infection by hiv
10/13/2011	WO2011127070A2 IRE-1α INHIBITORS
10/13/2011	WO2011126810A2 Intravaginal drug delivery device
10/13/2011	WO2011126576A2 Genetic signatures in the envelope glycoprotein of hiv-1

1 ... 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 ... 1798